Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
zhenyang Liu, MD PhD
CONTACT
xiaolin Yang, MD
CONTACT
Lead
Hunan Cancer Hospital
With
This is a prospective ,single-center, open labeled, single-arm phase II study exploring the efficacy and safety of fruquintinib combined with FOLFIRI as second-line treatment of RAS-mutated metastatic colorectal cancer (mCRC) in patients with disease progression during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine.
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted